Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
MV-130 by Inmunotek for Lower Respiratory Tract Infections: Likelihood of Approval
MV-130 is under clinical development by Inmunotek and currently in Phase II for Lower Respiratory Tract Infections. According to GlobalData,...